Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 25;22(1):522.
doi: 10.1186/s12877-022-03176-3.

Prescribing Alzheimer's Disease treatments by provider type and geographic region: a comparison among physicians, nurse practitioners, and physician assistants

Jenny Y Park  1   2 , David L Veenstra  3 , Christopher J Wallick  4 , Zachary A Marcum  3
Affiliations

Prescribing Alzheimer's Disease treatments by provider type and geographic region: a comparison among physicians, nurse practitioners, and physician assistants

Jenny Y Park et al. BMC Geriatr. .

Abstract

Background: The estimated increase in Alzheimer's Disease (AD) caseload may present a logistical challenge to the US healthcare system. While nurse practitioners (NPs) and physician assistants (PAs) are increasingly delivering primary care to patients with chronic diseases, the nature of their prescribing of AD medications is largely unknown. The primary objective of this study was to compare the prescribing of AD medications across provider types (physician, NP, and PA) and geographic regions.

Methods: We conducted a retrospective cohort study using IBM MarketScan® commercial and Medicare supplemental claims to examine unique AD prescriptions prescribed between January 1, 2016, and December 31, 2019. Parallel analysis of prescriptions for another geriatric condition, osteoporosis (OP), was also conducted for comparison.

Results: A total of 103,067 AD prescriptions and 131,773 OP prescriptions were included in analyses. Physicians prescribed most AD prescriptions (95.65%), followed by NPs (3.37%) and PAs (0.98%). Small differences were identified among individual AD medications prescribed by physicians compared to NP/PAs. NPs/PAs prescribed a significantly higher proportion of AD prescriptions in rural as compared to urban areas (z = 0.023, 95%CI [0.018, 0.028]).

Conclusion: Minimal variation exists in AD prescribing among physicians, NPs, and PAs, but NPs/PAs prescribe more AD prescriptions in rural areas. NPs/PAs, especially in rural areas, may play critical roles in alleviating projected workforce constraints. Further research assessing AD care, health outcomes, and costs by provider type and region is necessary to better guide healthcare workforce planning for AD care.

Keywords: Alzheimer’s Disease; Dementia; Geographic disparities; Prescribing patterns; Provider type; Rural; Urban.

PubMed Disclaimer

Conflict of interest statement

JY Park is a Postdoctoral Fellow in Health Economics and Outcomes Research (HEOR) with Genentech and the University of Washington Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute.

CJ Wallick is a full-time employee of Genentech.

DL Veenstra has served as a consultant to Genentech.

Figures

Fig. 1
Fig. 1
Cohort selection flowchart. Abbreviations: AD = Alzheimer’s Dementia, OP = Osteoporosis, ID = Identification, MSA = Metropolitan Statistical Area
Fig. 2
Fig. 2
Proportions of AD and OP medicines prescribed by NPs, PAs, and Physicians. Abbreviations: AD = Alzheimer’s Dementia, OP = Osteoporosis, NP = Nurse Practitioner, PA = Physician Assistant
Fig. 3
Fig. 3
The distribution of prescriptions and proportion of prescriptions written by non-physician PCPs (NPs/PAs) or specialist physicians by rurality. Abbreviations: PCP = Primary Care Provider, NP = Nurse Practitioner, PA = Physician Assistants, MD = Medical Doctor. The Non-Metro category incluedes rural and micropolitan counties
Fig. 4
Fig. 4
Heat maps depicting the proportion of prescriptions prescribed by specialist physicians in each county
See this image and copyright information in PMC

References

    1. 2021 Alzheimer's disease facts and figures. Alzheimers Dement. 2021;17(3):327–406. 10.1002/alz.12328. Epub 2021 Mar 23. - PubMed
    1. Prince M, Wimo A, Guerchet M, et al. The global impact of dementia. An analysis of prevalence, incidence, cost and trends. London: Alzheimer’s Disease International; 2015. World Alzheimer Report 2015.
    1. Liu JL, Hlavka JP, Hillestad R, et al. Assessing the preparedness of the health care system infrastructure in six European Countries for an Alzheimer's treatment. Rand Health Q. 2019;8(3):2. - PMC - PubMed
    1. Warshaw GA, Bragg EJ. Preparing the health care workforce to care for adults with Alzheimer's disease and related dementias. Health Aff (Millwood) 2014;33(4):633–641. doi: 10.1377/hlthaff.2013.1232. - DOI - PubMed
    1. Liss JL, SeleriAssunção S, Cummings J, Atri A, Geldmacher DS, Candela SF, Devanand DP, Fillit HM, Susman J, Mintzer J, Bittner T, Brunton SA, Kerwin DR, Jackson WC, Small GW, Grossberg GT, Clevenger CK, Cotter V, Stefanacci R, Wise-Brown A, Sabbagh MN. Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis. J Intern Med. 2021;290(2):310–334. doi: 10.1111/joim.13244. - DOI - PMC - PubMed

Publication types